Theriva Biologics (TOVX)
NYSE MKT:TOVX
Holding TOVX?
Track your performance easily

Theriva Biologics (TOVX) Financial Statements

1,014 Followers

Theriva Biologics Financial Overview

Theriva Biologics's market cap is currently ―. The company's EPS TTM is $-31.092; its P/E ratio is -0.12; Theriva Biologics is scheduled to report earnings on November 6, 2024, and the estimated EPS forecast is $-6.25. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -8.30M$ -5.17M$ -6.22M$ -3.83M$ -5.44M
EBITDA$ -8.26M$ -5.13M$ -6.18M$ -3.80M$ -5.41M
Net Income Common Stockholders$ -8.30M$ -5.20M$ -5.49M$ -3.30M$ -5.10M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 16.59M$ 18.26M$ 23.18M$ 31.16M$ 34.25M
Total Assets$ 42.39M$ 48.73M$ 55.22M$ 61.55M$ 65.45M
Total Debt$ 1.83M$ 2.02M$ 2.15M$ 2.22M$ 2.36M
Net Debt$ -14.76M$ -16.24M$ -21.02M$ -28.94M$ -31.89M
Total Liabilities$ 14.74M$ 14.61M$ 15.52M$ 17.66M$ 17.70M
Stockholders Equity$ 25.90M$ 31.39M$ 36.96M$ 41.15M$ 45.02M
Cash Flow-
Free Cash Flow$ -3.45M$ -4.88M$ -6.60M$ -3.08M$ -4.37M
Operating Cash Flow$ -3.45M$ -4.88M$ -6.54M$ -2.95M$ -4.36M
Investing Cash Flow$ -203.00K$ 202.00K$ -56.00K$ -129.00K$ 424.00K
Financing Cash Flow$ 1.77M-$ -1.46M$ 1.00K$ 2.14M
Currency in USD

Theriva Biologics Earnings and Revenue History

Theriva Biologics Debt to Assets

Theriva Biologics Cash Flow

Theriva Biologics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis